{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:02:43Z","timestamp":1769205763303,"version":"3.49.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01270","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:36:31Z","timestamp":1559835391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting Endothelial Barrier Dysfunction Caused by Circulating Bacterial and Mitochondrial N-Formyl Peptides With Deformylase"],"prefix":"10.3389","volume":"10","author":[{"given":"Patricia","family":"Martinez-Quinones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Komic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron G.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Clinton","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla Ferreira","family":"Wenceslau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med."},{"key":"B2","article-title":"National inpatient hospital costs: the most expensive conditions by Payer, 2013: statistical brief #204","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Torio","year":"2006"},{"key":"B3","unstructured":"TorioC MooreB National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013.2016"},{"key":"B4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS)","volume":"273","author":"Rangel-Frausto","year":"1995","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/smim.1998.0143","article-title":"An innate sense of danger","volume":"10","author":"Matzinger","year":"1998","journal-title":"Semin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"R237","DOI":"10.1186\/cc9392","article-title":"Genome-wide transcription profiling of human sepsis: a systematic review","volume":"14","author":"Tang","year":"2010","journal-title":"Crit Care."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1172\/JCI113431","article-title":"Interleukin 1 induces a shock-like state in rabbits","volume":"81","author":"Okusawa","year":"1988","journal-title":"J Clin Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00008480-200306000-00009","article-title":"Toll-like receptor signaling in sepsis","volume":"15","author":"Lakhani","year":"2003","journal-title":"Curr Opin Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mehy.2013.06.026","article-title":"Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis","volume":"81","author":"Wenceslau","year":"2013","journal-title":"Med Hypotheses."},{"key":"B15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/SLA.0b013e3182a4ea46","article-title":"Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects","volume":"258","author":"Simmons","year":"2013","journal-title":"Ann Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1097\/CCM.0000000000001311","article-title":"Mitochondrial DNA and Toll-like receptor-9 are associated with mortality in critically Ill patients","volume":"43","author":"Krychtiuk","year":"2015","journal-title":"Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pupt.2016.02.005","article-title":"Mitochondrial N-formyl peptides cause airway contraction and lung neutrophil infiltration via formyl peptide receptor activation","volume":"37","author":"Wenceslau","year":"2016","journal-title":"Pulm Pharmacol Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"H768","DOI":"10.1152\/ajpheart.00779.2014","article-title":"Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome","volume":"308","author":"Wenceslau","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e59989","DOI":"10.1371\/journal.pone.0059989","article-title":"Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3389\/fimmu.2018.00891","article-title":"Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage","volume":"9","author":"Aswani","year":"2018","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"187048","DOI":"10.1155\/2015\/187048","article-title":"Balancing innate immunity and inflammatory state via modulation of neutrophil function: a novel strategy to fight sepsis","volume":"2015","author":"Fang","year":"2015","journal-title":"J Immunol Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"The endothelium in sepsis","volume":"45","author":"Ince","year":"2016","journal-title":"Shock."},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0008-6363(03)00397-3","article-title":"Molecular basis of endothelial dysfunction in sepsis","volume":"60","author":"Peters","year":"2003","journal-title":"Cardiovasc Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/00003246-200712000-00002","article-title":"Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis","volume":"35","author":"Laupland","year":"2007","journal-title":"Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1097\/00003246-200712000-00003","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001090.pub2","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit. Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1074\/jbc.M114.626747","article-title":"Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens","volume":"290","author":"Bufe","year":"2015","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1073\/pnas.72.3.1059","article-title":"N-formylmethionyl peptides as chemoattractants for leucocytes","volume":"72","author":"Schiffmann","year":"1975","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/srep00786","article-title":"Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes","volume":"2","author":"Liu","year":"2012","journal-title":"Sci Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1126\/science.1195491","article-title":"Intravascular danger signals guide neutrophils to sites of sterile inflammation","volume":"330","author":"McDonald","year":"2010","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1097\/TA.0b013e3181dcd28d","article-title":"Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1","volume":"68","author":"Raoof","year":"2010","journal-title":"J Trauma."},{"key":"B37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.intimp.2015.08.036","article-title":"Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives","volume":"37","author":"Schepetkin","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2741\/e778","article-title":"The potential impacts of formyl peptide receptor 1 in inflammatory diseases","volume":"8","author":"Yang","year":"2016","journal-title":"Front Biosci (Elite Ed)."},{"key":"B39","doi-asserted-by":"crossref","first-page":"25395","DOI":"10.1016\/S0021-9258(19)74405-6","article-title":"Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains","volume":"268","author":"Gao","year":"1993","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0378-1119(93)90653-K","article-title":"Sequence and organization of the human N-formyl peptide receptor-encoding gene","volume":"133","author":"Murphy","year":"1993","journal-title":"Gene."},{"key":"B41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","article-title":"Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses","volume":"17","author":"Migeotte","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of basic and clinical pharmacology","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.bcp.2007.06.049","article-title":"The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1","volume":"74","author":"Stenfeldt","year":"2007","journal-title":"Biochem Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/imm.12324","article-title":"Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis","volume":"143","author":"Oldekamp","year":"2014","journal-title":"Immunology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","article-title":"Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease","volume":"300","author":"Kantarci","year":"2018","journal-title":"Exp Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.0803128","article-title":"Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils","volume":"182","author":"Devosse","year":"2009","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"33644","DOI":"10.1074\/jbc.M112.375774","article-title":"Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties","volume":"287","author":"Bufe","year":"2012","journal-title":"J Biol Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2016.00297","article-title":"Formyl peptide receptor activation elicits endothelial cell contraction and vascular leakage","volume":"7","author":"Wenceslau","year":"2016","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.phrs.2019.01.015","article-title":"Formyl peptide receptor-1 activation exerts a critical role for the dynamic plasticity of arteries via actin polymerization","volume":"141","author":"Wenceslau","year":"2019","journal-title":"Pharmacol Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/carcin\/bgn266","article-title":"Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation","volume":"30","author":"Huang","year":"2009","journal-title":"Carcinogenesis."},{"key":"B51","first-page":"2223","article-title":"Formyl peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer","volume":"34","author":"Cheng","year":"2014","journal-title":"Anticancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0163-7258(96)00203-3","article-title":"The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function","volume":"74","author":"Prossnitz","year":"1997","journal-title":"Pharmacol Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ajpath.2015.01.020","article-title":"The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation","volume":"185","author":"Dorward","year":"2015","journal-title":"Am J Pathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1021\/jm010987v","article-title":"Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor","volume":"45","author":"Loor","year":"2002","journal-title":"J Med Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10753-007-9040-4","article-title":"Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor","volume":"30","author":"Stenfeldt","year":"2007","journal-title":"Inflammation."},{"key":"B56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.189.4.657","article-title":"Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor","volume":"189","author":"Gao","year":"1999","journal-title":"J Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bcp.2016.04.014","article-title":"Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria","volume":"114","author":"Dahlgren","year":"2016","journal-title":"Biochem Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.jss.2013.03.023","article-title":"Eritoran attenuates tissue damage and inflammation in hemorrhagic shock\/trauma","volume":"184","author":"Korff","year":"2013","journal-title":"J Surg Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1083\/jcb.150.4.785","article-title":"Two pathways through Cdc42 couple the N-formyl receptor to actin nucleation in permeabilized human neutrophils","volume":"150","author":"Glogauer","year":"2000","journal-title":"J Cell Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"C1633","DOI":"10.1152\/ajpcell.00576.2005","article-title":"G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils","volume":"290","author":"Makino","year":"2006","journal-title":"Am J Physiol Cell Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/stem.1578","article-title":"WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells","volume":"32","author":"Heo","year":"2014","journal-title":"Stem Cells."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/eurheartj\/ehu047","article-title":"Mitochondrial damage-associated molecular patterns and vascular function","volume":"35","author":"Wenceslau","year":"2014","journal-title":"Eur Heart J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00109-009-0585-6","article-title":"The response of the host microcirculation to bacterial sepsis: does the pathogen matter?","volume":"88","author":"Legrand","year":"2010","journal-title":"J Mol Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1000045","DOI":"10.1371\/journal.ppat.1000045","article-title":"Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum","volume":"4","author":"Hickey","year":"2008","journal-title":"PLoS Pathog."},{"key":"B65","doi-asserted-by":"publisher","first-page":"672395","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signaling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00395-014-0459-0","article-title":"Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia\/reperfusion","volume":"110","author":"Yang","year":"2015","journal-title":"Basic Res Cardiol."},{"key":"B67","doi-asserted-by":"crossref","first-page":"12588","DOI":"10.1016\/S0021-9258(19)86355-X","article-title":"The relationship between human serum and human pancreatic DNase I","volume":"254","author":"Love","year":"1979","journal-title":"J Biol Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1744806917731696","DOI":"10.1177\/1744806917731696","article-title":"Endotracheal tube-induced sore throat pain and inflammation is coupled to the release of mitochondrial DNA","volume":"13","author":"Puyo","year":"2017","journal-title":"Mol Pain."},{"key":"B69","doi-asserted-by":"publisher","first-page":"149560","DOI":"10.1155\/2012\/149560","article-title":"Deoxyribonuclease is a potential counter regulator of aberrant neutrophil extracellular traps formation after major trauma","volume":"2012","author":"Meng","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/0929867321666140826115734","article-title":"Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery","volume":"22","author":"Sangshetti","year":"2015","journal-title":"Curr Med Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0005-2787(80)90133-1","article-title":"Initiation of protein synthesis in isolated mitochondria and chloroplasts","volume":"608","author":"Lucchini","year":"1980","journal-title":"Biochim Biophys Acta."},{"key":"B72","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S1472-9792(09)70013-7","article-title":"Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis","volume":"89","author":"Olaleye","year":"2009","journal-title":"Tuberculosis (Edinb)."},{"key":"B73","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/j.1460-2075.1994.tb06335.x","article-title":"Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation","volume":"13","author":"Mazel","year":"1994","journal-title":"EMBO J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.coph.2006.06.003","article-title":"Peptide deformylase as an antibacterial target: a critical assessment","volume":"6","author":"Leeds","year":"2006","journal-title":"Curr Opin Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1016\/j.bmcl.2008.10.040","article-title":"Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results","volume":"18","author":"Pichota","year":"2008","journal-title":"Bioorg Med Chem Lett."},{"key":"B76","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0022-2836(02)00549-1","article-title":"The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents","volume":"320","author":"Guilloteau","year":"2002","journal-title":"J Mol Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1046\/j.1365-2958.2000.01908.x","article-title":"Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents","volume":"36","author":"Giglione","year":"2000","journal-title":"Mol Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1128\/AAC.48.12.4835-4842.2004","article-title":"Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor","volume":"48","author":"Ramanathan-Girish","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/clpt.2011.101","article-title":"Pharmacokinetics and unexpected safety issues of LBM415, a novel oral peptide deformylase inhibitor","volume":"90","author":"Rolan","year":"2011","journal-title":"Clin Pharmacol Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1128\/MCB.00469-10","article-title":"Inhibition of human peptide deformylase disrupts mitochondrial function","volume":"30","author":"Escobar-Alvarez","year":"2010","journal-title":"Mol Cell Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.bbrc.2012.04.097","article-title":"Transcriptional regulation of the human mitochondrial peptide deformylase (PDF)","volume":"421","author":"Pereira-Castro","year":"2012","journal-title":"Biochem Biophys Res Commun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T18:27:52Z","timestamp":1663612072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":81,"alternative-id":["10.3389\/fimmu.2019.01270"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01270","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"article-number":"1270"}}